BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
QuintilesIMS
Chinese Patent Office
Teva
AstraZeneca
Merck
Farmers Insurance
Fuji
Accenture
Johnson and Johnson

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021994

« Back to Dashboard

NDA 021994 describes TRAVATAN Z, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the TRAVATAN Z profile page.

The generic ingredient in TRAVATAN Z is travoprost. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the travoprost profile page.
Summary for 021994
Tradename:TRAVATAN Z
Applicant:Novartis Pharms Corp
Ingredient:travoprost
Patents:3
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 021994
Ingredient-typeProstaglandins
Medical Subject Heading (MeSH) Categories for 021994
Suppliers and Packaging for NDA: 021994
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRAVATAN Z travoprost SOLUTION/DROPS;OPHTHALMIC 021994 NDA Alcon Laboratories, Inc 0065-0260 0065-0260-02 1 BOTTLE in 1 CARTON (0065-0260-02) > 2.5 mL in 1 BOTTLE
TRAVATAN Z travoprost SOLUTION/DROPS;OPHTHALMIC 021994 NDA Alcon Laboratories, Inc 0065-0260 0065-0260-05 1 BOTTLE in 1 CARTON (0065-0260-05) > 5 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.004%
Approval Date:Sep 21, 2006TE:ATRLD:Yes
Patent:➤ SubscribePatent Expiration:Oct 13, 2029Product Flag?YSubstance Flag?Delist Request?
Patent:➤ SubscribePatent Expiration:Sep 20, 2027Product Flag?YSubstance Flag?Delist Request?
Patent:➤ SubscribePatent Expiration:Sep 20, 2027Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 021994

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp TRAVATAN Z travoprost SOLUTION/DROPS;OPHTHALMIC 021994-001 Sep 21, 2006 ➤ Subscribe ➤ Subscribe
Novartis Pharms Corp TRAVATAN Z travoprost SOLUTION/DROPS;OPHTHALMIC 021994-001 Sep 21, 2006 ➤ Subscribe ➤ Subscribe
Novartis Pharms Corp TRAVATAN Z travoprost SOLUTION/DROPS;OPHTHALMIC 021994-001 Sep 21, 2006 ➤ Subscribe ➤ Subscribe
Novartis Pharms Corp TRAVATAN Z travoprost SOLUTION/DROPS;OPHTHALMIC 021994-001 Sep 21, 2006 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Federal Trade Commission
Baxter
Fuji
Mallinckrodt
Queensland Health
McKinsey
Chinese Patent Office
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot